Table 3 Dosimetry characteristics
Covariate | Overall (n = 117) | Lipiodol (n = 64) | No lipiodol (n = 53) | p-value |
|---|---|---|---|---|
Mean boost clinical target volume (cm3) (sd) [Missing] | 46.0Â cc (43.4) [8] | 36.8Â cc (28.0) [1] | 58.6Â cc (56.2) [7] | 0.02 |
Mean bladder volume (cm3) (sd) [Missing] | 257.5 cc (126.2) [9] | 268.7 cc (113.4) (n = 63) [1] | 241.8 cc (142.0) (n = 45) [8] | 0.17 |
Mean percentage of bladder volume receiving 95% of boost dose (sd) [Missing] | 58.4% (28.3) [47] | 51.5% (25.8) [17] | 72.6% (28.4) [30] | 0.004 |